Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Carrington Website

Mary N. Carrington, Ph.D.

Selected Publications

1)  Thomson R, Genovese G, Canon C, Kovacsics D, Higgins MK, Carrington M, Winkler CA, Kopp J, Rotimi C, Adeyemo A, Doumatey A, Ayodo G, Alper SL, Pollak MR, Friedman DJ, Raper J.
Evolution of the primate trypanolytic factor APOL1.
Proc. Natl. Acad. Sci. U.S.A. 2014.
[Journal]
2)  Cotton LA, Kuang XT, Le AQ, Carlson JM, Chan B, Chopera DR, Brumme CJ, Markle TJ, Martin E, Shahid A, Anmole G, Mwimanzi P, Nassab P, Penney KA, Rahman MA, Milloy MJ, Schechter MT, Markowitz M, Carrington M, Walker BD, Wagner T, Buchbinder S, Fuchs J, Koblin B, Mayer KH, Harrigan PR, Brockman MA, Poon AF, Brumme ZL.
Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.
PLoS Genet. 10: e1004295, 2014.
[Journal]
3)  Hiby SE, Apps R, Chazara O, Farrell LE, Magnus P, Trogstad L, Gjessing HK, Carrington M, Moffett A.
Maternal KIR in Combination with Paternal HLA-C2 Regulate Human Birth Weight.
J. Immunol. 192: 5069-73, 2014.
[Journal]
4)  Stewart S, Carrington MJ, Horowitz JD, Marwick TH, Newton PJ, Davidson PM, Macdonald P, Thompson DR, Chan YK, Krum H, Reid C, Scuffham PA.
Prolonged impact of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort.
Int. J. Cardiol. 2014.
[Journal]
5)  Chiu C, McCausland M, Sidney J, Duh FM, Rouphael N, Mehta A, Mulligan M, Carrington M, Wieland A, Sullivan NL, Weinberg A, Levin MJ, Pulendran B, Peters B, Sette A, Ahmed R.
Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.
PLoS Pathog. 10: e1004008, 2014.
[Journal]
6)  Bashirova AA, Apps R, Vince N, Mochalova Y, Yu XG, Carrington M.
Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.
Immunogenetics. 66: 1-8, 2014.
[Journal]
7)  Vince N, Bashirova AA, Lied A, Gao X, Dorrell L, McLaren PJ, Fellay J, Carrington M.
HLA class I and KIR genes do not protect against HIV-1 infection in highly exposed uninfected individuals with hemophilia A.
J. Infect. Dis. [Epub ahead of print], 2014.
[Journal]
8)  Bashirova AA, Martin-Gayo E, Jones DC, Qi Y, Apps R, Gao X, Burke PS, Taylor CJ, Rogich J, Wolinsky S, Bream JH, Duggal P, Hussain S, Martinson J, Weintrob A, Kirk GD, Fellay J, Buchbinder SP, Goedert JJ, Deeks SG, Pereyra F, Trowsdale J, Lichterfeld M, Telenti A, Walker BD, Allen RL, Carrington M, Yu XG.
LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.
PLoS Genet. 10: e1004196, 2014.
[Journal]
9)  Kroy DC, Ciuffreda D, Cooperrider JH, Tomlinson M, Hauck GD, Aneja J, Berger C, Wolski D, Carrington M, Wherry EJ, Chung RT, Tanabe KK, Elias N, Freeman GJ, de Kruyff RH, Misdraji J, Kim AY, Lauer GM.
Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.
Gastroenterology. 146: 550-61, 2014.
[Journal]
10)  McFarland AP, Horner SM, Jarret A, Joslyn RC, Bindewald E, Shapiro BA, Delker DA, Hagedorn CH, Carrington M, Gale M, Savan R.
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.
Nat. Immunol. 15: 72-9, 2014.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 5/21/2014.